Formats
  1. Journal Article (66894)
  2. Meeting Abstract (33621)
  3. Book Section (5097)
  4. Review (3749)
  5. Editorial (2165)
  6. Conference Paper (1526)
  7. Correspondence (663)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Book Whole (344)
  11. Miscellaneous (339)
Groups
  1. Department of Medicine (39043)
  2. GSK Faculty (22462)
  3. Solid Tumor Oncology Division (22061)
  4. Surgery (21262)
  5. Survivorship Research (15766)
  6. Sloan Kettering Institute Faculty (15652)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (2139)
  2. 2024 (5384)
  3. 2023 (5806)
  4. 2022 (6169)
  5. 2021 (5714)
  6. 2020 (5618)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4951)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2611)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13846)
  2. American Society of Clinical Oncology (9169)
  3. Springer (7192)
  4. Nature Publishing Group (6375)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5512)

More Publishers

Results (115607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion
    Correspondence

    Crowell, C.; Schollenberg, E.; Tran, T. H.; Wilson, D.; Bezuhly, M.; Mata‐Mbemba, D.; Antonescu, C. R.; Erker, C.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Final database lock results of the phase 2 cohort of lenvatinib + pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Shah, A. Y.; Rao, A.; Taylor, M. H.; Pinto, A.; Sarrio, R. G.; Cohn, A. L.; Bilen, M. A.; Ribe, S. G.; Goksel, M.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002
    Meeting Abstract

    Motzer, R. J.; Choueiri, T. K.; Garmezy, B.; O'Neil, B.; Michalski, J.; Barata, P.; Bajaj, A.; Chahoud, J.; Liu, M.; Xu, F.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Genetic basis of relapse after GPRCSD-targeted CAR T cells
    Research Letter

    Mi, X.; Penson, A.; Abdel-Wahab, O.; Mailankody, S.
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Preoperative treatment of locally advanced rectal cancer: The author replies
    Correspondence

    Schrag, D.
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Severe Bartonella quintana infections among persons experiencing unsheltered homelessness — New York City, January 2020–December 2022
    Editorial

    Rich, S. N.; Beeson, A.; Seifu, L.; Mitchell, K.; Wroblewski, D.; Juretschko, S.; Keller, M.; Gnanaprakasam, R.; Agladze, M.; Kodama, R.; more...
    MMWR (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): A randomised, open-label, multicentre, phase 3 trial
    Journal Article

    Rugo, H S.; Bardia, A.; Marmé, F.; Cortés, J.; Schmid, P.; Loirat, D.; Trédan, O.; Ciruelos, E.; Dalenc, F.; Gómez Pardo, P.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • High-risk clinicopathologic and genomic features of recurrence in stage I lung adenocarcinoma
    Meeting Abstract

    Fick, C. N.; Dunne, E. G.; Mastrogiacomo, B.; Tan, K. S.; Toumbacaris, N.; Adusumilli, P. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save